Literature DB >> 3894558

Prolactin permits the expression of a circadian variation in lipogenic responsiveness to insulin in hepatocytes of the golden hamster (Mesocricetus auratus).

A H Cincotta, A H Meier.   

Abstract

Lipogenesis was determined at two times (07.00 and 16.00 h) during a 14-h daily photoperiod (08.00-22.00 h) in freshly prepared hamster hepatocytes with or without addition of insulin. The hamsters were pretreated for 5 days with bromocriptine (to inhibit prolactin secretion), bromocriptine and prolactin replacement, or control saline injections. Lipogenesis was determined by incorporation of [14C]acetate into total cell lipids over a 30-min interval. Lipogenesis was three times greater at 07.00 than at 16.00 h and insulin was effective in stimulating further lipogenesis only at 07.00 h. Bromocriptine pretreatment severely reduced incorporation of radiolabel at 07.00 h to levels comparable with controls at 16.00 h and completely inhibited the stimulatory effect of insulin at 07.00 h. Prolactin replacement in bromocriptine-treated hamsters reversed the inhibitory effect of bromocriptine on hepatocyte lipogenesis and promoted dramatic lipogenic responses to insulin at 07.00 h. These results indicate that insulin stimulates hepatic lipogenesis only during some portion of a day and that prolactin facilitates the lipogenic response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894558     DOI: 10.1677/joe.0.1060173

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Reduction of body fat stores by inhibition of prolactin secretion.

Authors:  A H Cincotta; A H Meier
Journal:  Experientia       Date:  1987-04-15

2.  Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.

Authors:  Mary Courtney Moore; Marta S Smith; Larry L Swift; Anthony H Cincotta; Michael Ezrokhi; Nicholas Cominos; Yahong Zhang; Ben Farmer; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-27       Impact factor: 4.310

3.  Disentangling environmental drivers of circadian metabolism in desert-adapted mice.

Authors:  Jocelyn P Colella; Danielle M Blumstein; Matthew D MacManes
Journal:  J Exp Biol       Date:  2021-09-27       Impact factor: 3.308

4.  Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics.

Authors:  A H Meier; A H Cincotta; W C Lovell
Journal:  Experientia       Date:  1992-03-15

5.  Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.

Authors:  Gitanjali Sharma; Anil Kumar Mishra; Pushpa Mishra; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2009-11-06       Impact factor: 3.246

6.  Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats.

Authors:  Michael Ezrokhi; Shuqin Luo; Yelena Trubitsyna; Anthony H Cincotta
Journal:  Diabetol Metab Syndr       Date:  2014-09-25       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.